Efficacy and Safety of Immunosuppressive Therapy in Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysisPlain-Language Summary
Rationale & Objective: Focal segmental glomerulosclerosis (FSGS) is a rare condition that can lead to kidney function decline and chronic kidney failure. Immunosuppressants are used to treat primary FSGS. However, their efficacy and safety in FSGS are not clearly established. We assessed cur...
Main Authors: | Dawn J. Caster, Barbara Magalhaes, Natali Pennese, Andrea Zaffalon, Marina Faiella, Kirk N. Campbell, Jai Radhakrishnan, Vladmir Tesar, Howard Trachtman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | Kidney Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590059522001224 |
Similar Items
-
Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-AnalysisPlain-Language Summary
by: Kirk N. Campbell, et al.
Published: (2022-05-01) -
Long‐term prognosis of focal segmental glomerulosclerosis treated with therapeutic low‐density lipoprotein‐apheresis in patients with severe kidney dysfunction and proteinuria
by: Shinji Kitajima, et al.
Published: (2023-03-01) -
Collapsing focal segmental glomerulosclerosis: Increasing the awareness
by: Muhammed Mubarak
Published: (2012-07-01) -
Focal segmental glomerulosclerosis and end-stage kidney disease in children
by: Gheissari Alaleh
Published: (2015-04-01) -
Renal transplantation in a patient with Bartter syndrome and glomerulosclerosis
by: Se Eun Lee, et al.
Published: (2011-01-01)